Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02621476 · ClinicalTrials.gov registry record · NA
Encouraging Mail Order Pharmacy Use to Improve Outcomes and Reduce Disparities
A NA study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 63,012
- Enrollment target
NCT02621476 is a NA study that has completed, run by Kaiser Permanente. The registered enrollment target is 63,012 participants.
The verdict
NCT02621476, a NA study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 63,012 participants
- Enrollment target
Study Summary
The investigators propose a randomized encouragement trial to encourage use of the existing mail order pharmacy services among diabetes patients with poor adherence to CVD risk factor medications in 3 health care systems: Kaiser Permanente Northern California, Harvard Pilgrim, and Kaiser Permanente Hawaii.
Interventions
- BEHAVIORAL Usual care
- BEHAVIORAL Standardized intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63,012 participants |
| Start Date | 2017-02-01 |
| Est. Completion | 2022-05-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02621476
The ClinicalTrials.gov registry entry for NCT02621476 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 63,012 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Usual care is the first listed.
NCT02621476 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02621476 about?
NCT02621476 is a clinical study titled "Encouraging Mail Order Pharmacy Use to Improve Outcomes and Reduce Disparities". The investigators propose a randomized encouragement trial to encourage use of the existing mail order pharmacy services among diabetes patients with poor adherence to CVD risk factor medications in 3 health care systems: Kaiser Permanente Northern California, Harvard Pilgrim, and Kaiser Permanente ...
What is the current status of trial NCT02621476?
This trial is currently completed. It is a NA study. The enrollment target is 63,012 participants. The study started on 2017-02-01. Estimated completion is 2022-05-30.
What interventions are being tested in trial NCT02621476?
The interventions under investigation include: Usual care (BEHAVIORAL), Standardized intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT02621476?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.